Motley Fool Asset Management LLC Has $4.30 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Motley Fool Asset Management LLC reduced its stake in The Cooper Companies, Inc. by 29.3%, selling 21,133 shares and retaining 50,960 shares valued at approximately $4.3 million as of the latest filing with the SEC.
• Securities bought by other hedge funds included a significant new stake worth $55.4 million from Nuveen LLC, while JPMorgan Chase & Co. lifted its holdings by 3.4% during the same quarter.
• Cooper Companies reported a revenue increase of 6.3% year-over-year to $1 billion, with an earnings per share of $0.96, exceeding analyst expectations.

Motley Fool Asset Management LLC decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,960 shares of the medical device company's stock after selling 21,133 shares during the period. Motley Fool Asset Management LLC's holdings in Cooper Companies were worth $4,298,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC increased its holdings in shares of Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after buying an additional 1,095,805 shares in the last quarter. Capital Fund Management S.A. purchased a new position in shares of Cooper Companies during the 4th quarter valued at $3,406,000. Treasurer of the State of North Carolina grew its holdings in shares of Cooper Companies by 0.5% during the 4th quarter. Treasurer of the State of North Carolina now owns 88,167 shares of the medical device company's stock valued at $8,105,000 after acquiring an additional 400 shares in the last quarter. Covestor Ltd boosted its holdings in Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Townsquare Capital LLC boosted its holdings in Cooper Companies by 8.6% in the fourth quarter. Townsquare Capital LLC now owns 116,095 shares of the medical device company's stock worth $10,673,000 after purchasing an additional 9,165 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of COO traded down $0.83 during trading hours on Thursday, reaching $73.44. 1,116,760 shares of the company traded hands, compared to its average volume of 2,163,684. The stock's fifty day moving average is $71.86 and its 200 day moving average is $79.46. The stock has a market cap of $14.69 billion, a P/E ratio of 35.65, a price-to-earnings-growth ratio of 1.77 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the prior year, the business earned $0.85 earnings per share. The firm's revenue for the quarter was up 6.3% on a year-over-year basis. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a report on Tuesday, July 22nd. Loop Capital set a $100.00 target price on shares of Cooper Companies in a research report on Tuesday, June 17th. Robert W. Baird cut their target price on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. Wells Fargo & Company cut their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.